Description

HIV 1/2 Ab Rapid Test

Accurate & Rapid Screening for HIV-1 and HIV-2 Antibodies

Product Overview

The HIV 1/2 Ab Rapid Test is a highly efficient and reliable in vitro diagnostic device designed for the qualitative detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human whole blood, serum, or plasma specimens. Utilizing advanced immunochromatographic technology, this test provides rapid, clear, and easy-to-interpret results, making it an invaluable tool for preliminary screening in diverse healthcare settings, outreach programs, and emergency situations where timely results are critical.

Key Features & Benefits

• Rapid Results: Obtain reliable results within 10-20 minutes, enabling quick decision-making and patient management.
• High Sensitivity & Specificity: Engineered for superior diagnostic accuracy, minimizing false positives and false negatives (specific performance metrics available upon request/refer to IFU).
• User-Friendly Design: Simple, single-step procedure requires minimal training and no specialized equipment, making it ideal for point-of-care (POC) testing.
• Multiple Specimen Types: Compatible with whole blood (fingerstick or venipuncture), serum, or plasma, offering flexibility in sample collection.
• Built-in Control Line: Includes an internal procedural control to confirm proper test performance and reagent integrity.
• Individual Packaging: Each test cassette is individually sealed in a foil pouch with a desiccant, ensuring stability, hygiene, and extended shelf life.
• Visual Interpretation: Results are easily read by the naked eye through distinct colored lines.
• Cost-Effective: Provides an affordable solution for widespread screening initiatives and resource-limited settings.
• Portable & Compact: Easy to store and transport, facilitating testing in remote locations or mobile clinics.

Principle of the Test

The HIV 1/2 Ab Rapid Test operates on the principle of immunochromatographic lateral flow assay. The test device contains a membrane strip pre-coated with recombinant HIV antigens (e.g., gp41, p24 for HIV-1; gp36 for HIV-2) on the test line (T) and goat anti-mouse IgG on the control line (C). When a specimen containing HIV-1 or HIV-2 antibodies is added to the sample well, these antibodies bind to the gold-conjugated HIV antigens present in the conjugate pad, forming an antigen-antibody complex. As this complex migrates along the membrane via capillary action, it is captured by the immobilized recombinant HIV antigens on the test line, forming a visible colored line (T). The control line (C) always appears, confirming that the test has been performed correctly and the reagents are functional.

Specimen Requirements

• Type: Whole Blood (fingerstick or venipuncture), Serum, or Plasma.
• Volume: Typically 10 µL of specimen (refer to specific kit instructions).
• Storage:
  • Whole blood should be tested immediately or stored at 2-8°C for up to 2 days.
  • Serum and plasma specimens can be stored at 2-8°C for up to 3 days or frozen at -20°C for longer periods. Avoid repeated freeze-thaw cycles.
• Preparation: Allow specimens to reach room temperature (15-30°C) prior to testing.

Test Procedure (Simplified)

1. Preparation: Allow the test cassette, specimen, and buffer to reach room temperature (15-30°C) prior to testing.
2. Open Pouch: Remove the test cassette from its sealed foil pouch and place it on a clean, flat surface.
3. Add Specimen: Using a dropper, add the specified volume of specimen (e.g., 10 µL of serum/plasma or one drop of whole blood) into the sample well (S) of the test cassette.
4. Add Buffer: Immediately add 2-3 drops of assay buffer into the sample well (S).
5. Start Timer: Begin timing.
6. Read Results: Read the results at 10-20 minutes. Do not interpret results after 20 minutes.

Interpretation of Results

• Positive Result: Two distinct colored lines appear. One line appears in the control region (C), and another line appears in the test region (T). This indicates the presence of antibodies to HIV-1 and/or HIV-2. Confirmatory testing is mandatory.
  • (Image/Diagram showing C and T lines)
• Negative Result: Only one colored line appears in the control region (C). No visible line appears in the test region (T). This indicates the absence of detectable HIV-1/2 antibodies.
  • (Image/Diagram showing C line only)
• Invalid Result: The control line (C) fails to appear. This indicates insufficient specimen volume, incorrect procedural techniques, or reagent deterioration. Review the procedure and repeat the test with a new device.
  • (Image/Diagram showing no C line)

Advantages for Healthcare Providers

• Early Intervention: Facilitates rapid identification of potential HIV infection, allowing for prompt counseling, linkage to care, and initiation of treatment.
• Community Screening: Ideal for large-scale screening programs, particularly in hard-to-reach populations, due to its simplicity and portability.
• Resource Optimization: Reduces the reliance on complex laboratory infrastructure and trained personnel, optimizing healthcare resources.
• Patient Compliance: Quicker results can improve patient engagement and follow-up rates.

Storage & Stability

• Store the test kit at room temperature or refrigerated (2-30°C / 36-86°F).
• Do not freeze.
• Keep the test cassette sealed in its original foil pouch until use.
• Shelf life: Typically 24 months from the date of manufacture (refer to individual kit labeling for exact expiry date).

Important Considerations & Limitations

• Screening Tool Only: This test is for screening purposes only and is not intended for diagnosis of HIV infection. All positive results must be confirmed by a more specific, independent laboratory method (e.g., Western Blot, ELISA, NAT).
• Window Period: A negative result does not definitively rule out HIV infection, especially if the individual has been recently exposed to HIV. Antibodies may not be detectable during the "window period" (the time between infection and the appearance of detectable antibodies, which can vary from weeks to months).
• Professional Use: The test is intended for use by trained healthcare professionals or under their supervision.
• No Differentiation: This test typically indicates the presence of antibodies to HIV-1 and/or HIV-2 but may not differentiate between the two types.
• Specimen Quality: Hemolyzed, lipemic, or contaminated specimens may affect test performance.
• Strict Adherence to Instructions: Incorrect procedure or inadequate sample volume can lead to inaccurate results.

Ordering Information

• Product Code: [e.g., HIVAB-RT-001]
• Pack Size Options:
  • 1 Test / Kit
  • 25 Tests / Kit
  • 50 Tests / Kit
  • 100 Tests / Kit
• Kit Contents (per test): Individually pouched test cassette, disposable dropper, buffer vial, package insert. (Gloves, alcohol swabs, lancets may be sold separately or included based on kit configuration).

Disclaimer: For in vitro diagnostic use only. Please read the complete product insert carefully before performing the test. Results should always be interpreted in conjunction with other clinical information and patient history. Consult a healthcare professional for diagnosis and treatment.